124 related articles for article (PubMed ID: 9744767)
21. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine differentiation and prognosis of extrahepatic biliary tract carcinomas.
Hsu W; Deziel DJ; Gould VE; Warren WH; Gooch GT; Staren ED
Surgery; 1991 Oct; 110(4):604-10; discussion 610-1. PubMed ID: 1718046
[TBL] [Abstract][Full Text] [Related]
24. PGP 9.5, a new marker for human neuroendocrine tumours.
Rode J; Dhillon AP; Doran JF; Jackson P; Thompson RJ
Histopathology; 1985 Feb; 9(2):147-58. PubMed ID: 2580771
[TBL] [Abstract][Full Text] [Related]
25. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
Takehara K; Sakai H; Shono T; Irie J; Kanetake H
Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
[TBL] [Abstract][Full Text] [Related]
26. Morphological changes in the adrenal cortex in different variants of low-renin hyperaldosteronism. Comparison with the functional state of certain hormonal systems.
Shkhvatsabaya IK; Bronstein ME; Chikhladze NM; Kazeev KN; Yureva NP; Kuratev LV
Cor Vasa; 1985; 27(2-3):103-10. PubMed ID: 3896645
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment.
Guate JL; Escaf S; Menendez CL; del Valle M; Vega JA
Urol Int; 1997; 59(3):149-53. PubMed ID: 9428430
[TBL] [Abstract][Full Text] [Related]
28. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
[TBL] [Abstract][Full Text] [Related]
30. Primary aldosteronism due to adrenal cortical carcinoma.
Sakashita S; Kashiwagi A; Maru A; Ito Y; Chiba H; Kurosawa S; Inoue K; Koyanagi T
J Urol; 1984 Nov; 132(5):959-61. PubMed ID: 6492288
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine differentiation in breast lesions.
Nesland JM; Holm R; Johannessen JV; Gould VE
Pathol Res Pract; 1988 Apr; 183(2):214-21. PubMed ID: 3290869
[TBL] [Abstract][Full Text] [Related]
32. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
33. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
34. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
35. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
36. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
Abrahamsson PA; Falkmer S; Fält K; Grimelius L
Pathol Res Pract; 1989 Sep; 185(3):373-80. PubMed ID: 2813190
[TBL] [Abstract][Full Text] [Related]
37. Role of interleukin-6 in stress response in normal and tumorous adrenal cells and during chronic inflammation.
Willenberg HS; Päth G; Vögeli TA; Scherbaum WA; Bornstein SR
Ann N Y Acad Sci; 2002 Jun; 966():304-14. PubMed ID: 12114287
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of endothelin-1-related protein in human adrenal cortex and in cortical lesions.
Li Q; Grimelius L; Höög A; Johansson H; Kjellman M; Larsson A
Histochem Cell Biol; 1999 Jan; 111(1):33-7. PubMed ID: 9930881
[TBL] [Abstract][Full Text] [Related]
39. Nuclear DNA patterns in adrenal cortex proliferative lesions.
Díaz-Cano S; González-Cámpora R; Ríos-Martín JJ; Lerma-Puertas E; Jordà-Heras M; Vázquez-Ramírez F; Bibbo M; Galera-Davidson H
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):323-8. PubMed ID: 8116223
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
